Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

active_not_recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

NCT06269913
active_not_recruitingnot_applicable

A Novel Iron-Based Supplement for Athletes Aged 14-17

NCT06338787
completednot_applicable

A Novel Iron Supplement for Athletes: Phase I

NCT06285851
completednot_applicable

Cost-Effectiveness Analysis of a Rehabilitation Protocol With FES Cycling in Persons With Complete SCI

NCT04592679

Clinical Trials (4)

Showing 4 of 4 trials
NCT06269913Not Applicable

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

Active Not Recruiting
NCT06338787Not Applicable

A Novel Iron-Based Supplement for Athletes Aged 14-17

Active Not Recruiting
NCT06285851Not Applicable

A Novel Iron Supplement for Athletes: Phase I

Completed
NCT04592679Not Applicable

Cost-Effectiveness Analysis of a Rehabilitation Protocol With FES Cycling in Persons With Complete SCI

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4